The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D Harding(Neurosciences Institute), Doriano Fabbro(Novartis (Switzerland)), Sam M Ireland(Institute of Structural and Molecular Biology), Alasdair J. G. Gray(Heriot-Watt University), Elena Faccenda(University of Edinburgh), Christopher Southan(University of Edinburgh), Christian Doerig(RMIT University), Clare Bryant(University of Cambridge), Francesca Levi‐Schaffer(Hebrew University of Jerusalem), Liam Bruce(Heriot-Watt University), Anthony P. Davenport(University of Cambridge), Joanna L Sharman(University of Edinburgh), Michael Spedding(Ta Solutions (China)), Jamie A. Davies(University of Edinburgh), S P H Alexander(University of Nottingham), Adam J Pawson(University of Edinburgh), Stephen M. Anderton(Centre for Inflammation Research)
Cited by 1,655
Related Papers
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity
|Molecular Cancer Therapeutics|2008|1.1k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
|Nucleic Acids Research|2015|1k
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
|Nucleic Acids Research|2013|860
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712